2024-11-22 13:31:49
Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7
Health/ 2023-09-14
Caliway Announces CBL-514 Phase 2 Study ...

- CBL-0201DD Phase 2 study met the primary and all secondary endpoints. - 64.5% of painful lipomas showed complete clearance or dimensions r...

Maxigen Biotech Inc. Wins 2023 Asia's Leading SMEs Award for Innovative Sustainability
Health/ 2023-09-14
Maxigen Biotech Inc. Wins 2023 Asia'...

KUALA LUMPUR,Malaysia,Sept. 13,2023-- Maxigen Biotech Inc.(MBI),a pioneering biotech company headquartered in Taiwan,has been honored with t...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release